Dobutamine
-
Dobutamine
structure -
-
CAS No:
34368-04-2
-
Formula:
C18H23NO3
-
Chemical Name:
Dobutamine
-
Synonyms:
1,2-Benzenediol,4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-;1,2-Benzenediol,4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]ethyl]-,(±)-;4-[2-[[3-(4-Hydroxyphenyl)-1-methylpropyl]amino]ethyl]-1,2-benzenediol;Dobutamine;(±)-Dobutamine;DL-Dobutamine;Racemic dobutamine;Compound 81929;67230-43-7
- Categories:
-
CAS No:
Description
ChEBI: A catecholamine that is 4-(3-aminobutyl)phenol in which one of the hydrogens attached to the nitrogen is substituted by a 2-(3,4-dihydroxyphenyl)ethyl group. A beta1-adrenergic receptor agonist that has cardiac stimulan action without evoking vasoconstriction or tachycardia, it is used as the hydrochloride to increase the contractility of the heart in the management of acute heart failure.
Solid
Dobutamine is a catecholamine that is 4-(3-aminobutyl)phenol in which one of the hydrogens attached to the nitrogen is substituted by a 2-(3,4-dihydroxyphenyl)ethyl group. A beta1-adrenergic receptor agonist that has cardiac stimulant action without evoking vasoconstriction or tachycardia, it is used as the hydrochloride to increase the contractility of the heart in the management of acute heart failure. It has a role as a cardiotonic drug, a sympathomimetic agent and a beta-adrenergic agonist. It is a secondary amine and a catecholamine.|A beta-1 agonist catecholamine that has cardiac stimulant action without evoking vasoconstriction or tachycardia. It is proposed as a cardiotonic after myocardial infarction or open heart surgery.|A catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY.
Dobutamine Basic Attributes
337.84
301.38
277-982-4
DTXSID3022958
C01CA07|C - Cardiovascular system
2922509090
Characteristics
72.72000
3.34770
Solid
1.189g/cm3
184-186
527.7ºC at 760mmHg
169.8ºC
1.37e-02 g/L
2-8°C
168.2 Ų [M+H]+ [CCS Type: TW, Method: Major Mix IMS/Tof Calibration Kit (Waters)]
Safety Information
3
20/21/22-63
22-26-36/37/39
Xn
P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P312, P322, P330, P363, P501
H302
Drug Information
Indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures.|Treatment of neonatal circulatory failure
Dobutamine is a direct-acting inotropic agent whose primary activity results from stimulation of the beta-adrenoceptors of the heart while producing comparatively mild chronotropic, hypertensive, arrhythmogenic, and vasodilative effects. Dobutamine acts primarily on beta-1 adrenergic receptors, with negligible effects on beta-2 or alpha receptors. It does not cause the release of endogenous norepinephrine, as does dopamine.
Compounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Agonists.)|Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)|Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
In human urine, the major excretion products are the conjugates of dobutamine and 3-O-methyl dobutamine.
2 minutes
Dobutamine directly stimulates beta-1 receptors of the heart to increase myocardial contractility and stroke volume, resulting in increased cardiac output.
Dobucor
Dobutamine Use and Manufacturing
This product is a β-receptor stimulant, which can enhance myocardial contractility and cardiac output, and is also used for the treatment of acute circulatory insufficiency. Rat oral LD50 is 2296-2783mg/kg.
Human Drugs -> EU pediatric investigation plans|Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients|Pharmaceuticals
Computed Properties
Molecular Weight:301.4
XLogP3:3.4
Hydrogen Bond Donor Count:4
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:7
Exact Mass:301.16779360
Monoisotopic Mass:301.16779360
Topological Polar Surface Area:72.7
Heavy Atom Count:22
Complexity:305
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
Dobutamine hydrochloride
49745-95-1
-
4,4′-(1,2-Diazenediyl)bis[N,N,N-trimethylbenzenaminium]
21704-61-0
-
N-(4-Chloro-2-methylphenyl)formamide
21787-81-5
-
Basic Blue 8 Formula
2185-87-7
-
3-tert-butyl-5-chloro-2-hydroxy-N-(2-nitrosophenyl)benzamide Formula
21889-00-9
-
1-Phenylcyclohexylamine Formula
2201-24-3
-
6-Hydroxymelatonin Structure
2208-41-5
-
Pyrrocaine Structure
2210-77-7
-
What is 2-amino-N-(4-ethoxyphenyl)ethanesulfonamide
22103-30-6
-
What is Bufeniode
22103-14-6